Status:
UNKNOWN
Outpatient Oncology Aromatherapy for Symptom Management
Lead Sponsor:
Central DuPage Hospital
Conditions:
Anxiety
Nausea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to determine whether using aromatherapy during chemotherapy infusion treatments in the outpatient Oncology setting promote relief of nausea and anxiety. The obje...
Detailed Description
Subject Selection: Every outpatient oncology patient experiencing nausea and/or anxiety during an infusion visit will be offered hospital-approved aromatherapy of Peppermint oil or Lavender oil. If pa...
Eligibility Criteria
Inclusion
- All outpatient Oncology patients \> 18 years of age Non pregnant Not cognitively impaired English speaking only Patients who report nausea and/or anxiety
Exclusion
- All outpatient oncology patients \<18 years of age Pregnant Cognitively impaired Non-English Speaking Patients who do not report nausea and/or anxiety Patients with a known allergy to peppermint and/or lavender aromatherapy oil
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04449315
Start Date
August 1 2020
End Date
June 1 2021
Last Update
June 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central DuPage
Winfield, Illinois, United States, 60190